# EFFECTIVENESS of PROBIOTICS in ADULTS with MODERATE to SEVERE PERSISTENT ASTHMA

> **NCT06657066** · PHASE2,PHASE3 · COMPLETED · sponsor: **King Edward Medical University** · enrollment: 74 (actual)

## Conditions studied

- Asthma Patients

## Interventions

- **DRUG:** Beclomethasone 200mcg, salbutamol 100mcg , Beclomethasone 200 mcg/Formoterol 6 mcg, 250 mg of lyophilized saccharomyces boulardii
- **DRUG:** Control (Standard treatment)

## Key facts

- **NCT ID:** NCT06657066
- **Lead sponsor:** King Edward Medical University
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-12-06
- **Primary completion:** 2022-04-24
- **Final completion:** 2023-08-08
- **Target enrollment:** 74 (ACTUAL)
- **Last updated:** 2024-10-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06657066

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06657066, "EFFECTIVENESS of PROBIOTICS in ADULTS with MODERATE to SEVERE PERSISTENT ASTHMA". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06657066. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*